Literature DB >> 16408095

CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance.

A Zucchetto, R Bomben, M Dal Bo, P Bulian, D Benedetti, P Nanni, G Del Poeta, M Degan, V Gattei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16408095     DOI： 10.1038/sj.leu.2404087

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.

Authors:  F Arruga; B Gizdic; S Serra; T Vaisitti; C Ciardullo; M Coscia; L Laurenti; G D'Arena; O Jaksic; G Inghirami; D Rossi; G Gaidano; S Deaglio
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

2.  Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells.

Authors:  Silvia Mele; Stephen Devereux; Andrea G Pepper; Elvira Infante; Anne J Ridley
Journal:  Blood Adv       Date:  2018-07-10

Review 3.  Management of chronic lymphocytic leukemia.

Authors:  Paolo Ghia; Michael Hallek
Journal:  Haematologica       Date:  2014-06       Impact factor: 9.941

4.  CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.

Authors:  Erika Tissino; Federico Pozzo; Dania Benedetti; Chiara Caldana; Tamara Bittolo; Francesca Maria Rossi; Riccardo Bomben; Paola Nanni; Hillarj Chivilò; Ilaria Cattarossi; Eva Zaina; Kevin Norris; Jerry Polesel; Massimo Gentile; Giovanni Tripepi; Riccardo Moia; Enrico Santinelli; Idanna Innocenti; Jacopo Olivieri; Giovanni D'Arena; Luca Laurenti; Francesco Zaja; Gabriele Pozzato; Annalisa Chiarenza; Francesco Di Raimondo; Davide Rossi; Chris Pepper; Tanja Nicole Hartmann; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei; Antonella Zucchetto
Journal:  Blood       Date:  2020-04-09       Impact factor: 22.113

5.  Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia.

Authors:  Omar Perbellini; Erika Falisi; Ilaria Giaretta; Elisa Boscaro; Elisabetta Novella; Monica Facco; Stefania Fortuna; Silvia Finotto; Eliana Amati; Francesco Maniscalco; Anna Montaldi; Alberta Alghisi; Fiorenza Aprili; Laura Bonaldi; Rossella Paolini; Maria Teresa Scupoli; Livio Trentin; Achille Ambrosetti; Gianpietro Semenzato; Giovanni Pizzolo; Francesco Rodeghiero; Carlo Visco
Journal:  Haematologica       Date:  2014-01-10       Impact factor: 9.941

Review 6.  CD38 and chronic lymphocytic leukemia: a decade later.

Authors:  Fabio Malavasi; Silvia Deaglio; Rajendra Damle; Giovanna Cutrona; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

Review 7.  Prognostic factors in chronic lymphocytic leukemia.

Authors:  Neil E Kay; Tait D Shanafelt
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 3.952

8.  CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Authors:  Tait D Shanafelt; Susan M Geyer; Nancy D Bone; Renee C Tschumper; Tom E Witzig; Greg S Nowakowski; Clive S Zent; Tim G Call; Betsy Laplant; Gordon W Dewald; Diane F Jelinek; Neil E Kay
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998

9.  CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

Authors:  Pietro Bulian; Tait D Shanafelt; Chris Fegan; Antonella Zucchetto; Lilla Cro; Holger Nückel; Luca Baldini; Antonina V Kurtova; Alessandra Ferrajoli; Jan A Burger; Gianluca Gaidano; Giovanni Del Poeta; Chris Pepper; Davide Rossi; Valter Gattei
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

10.  Association of CD49d expression with clinicopathological features of chronic lymphocytic leukemia patients in the Iranian population.

Authors:  Pardis Nematollahi; Mina Shakery; Amirhosein Kefayat; Parvin Goli
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.